Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colistin Dosing Strategies in MDR Gram-Negative Infections
NCT06843668Phase 3Recruiting
- Sponsor
- Mansoura University
- Start
- Dec 2023
- Primary completion
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of colistimethate sodium in Gram-negative bacterial infection, sponsored by Mansoura University. Started Dec 2023; status: recruiting.
02
Drugs
colistimethate sodium
03
Conditions
Gram-negative bacterial infection
Beyond the preview
Go deeper on NCT06843668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06843668.